ZFIN ID: ZDB-FISH-200521-27
Fish name: epg5ia31/ia31
Genotype: epg5ia31/ia31
Targeting Reagent: none
HUMAN DISEASE MODELED by epg5ia31/ia31
Human Disease Conditions Citations
Vici syndrome standard conditions Meneghetti et al., 2019
GENE EXPRESSION
Gene expression in epg5ia31/ia31
RNA expression No data available
Protein expression
Antibody Antigen Genes Structure Conditions Figures
Ab9-map1lc3b fasting Fig. 4 from Meneghetti et al., 2019
Reporter gene expression No data available
PHENOTYPE
Phenotype in epg5ia31/ia31
Phenotype Conditions Figures
autophagy disrupted, abnormal standard conditions Fig. 3 from Meneghetti et al., 2019
goblet cell decreased amount, abnormal standard conditions Fig. 5Fig. S2 from Meneghetti et al., 2019
goblet cell decreased area, abnormal standard conditions Fig. S2 from Meneghetti et al., 2019
goblet cell mucin granule dense, abnormal standard conditions Fig. 6 from Meneghetti et al., 2019
heart morphology, abnormal standard conditions Fig. 8 from Meneghetti et al., 2019
intestinal epithelium degenerate, abnormal standard conditions Fig. S9 from Meneghetti et al., 2019
intestinal mucosa morphology, abnormal standard conditions Fig. S9 from Meneghetti et al., 2019
intestinal stem cell homeostasis disrupted, abnormal standard conditions Fig. 5 from Meneghetti et al., 2019
intestine apoptotic process increased occurrence, abnormal standard conditions Fig. 5 from Meneghetti et al., 2019
intestine chordoma increased amount, abnormal standard conditions Fig. S10 from Meneghetti et al., 2019
intestine mitochondrion swollen, abnormal standard conditions Fig. 6 from Meneghetti et al., 2019
intestine somatic stem cell decreased amount, abnormal standard conditions Fig. 5 from Meneghetti et al., 2019
liver increased size, abnormal standard conditions Fig. S11 from Meneghetti et al., 2019
myocardium condensed, abnormal standard conditions Fig. S5 from Meneghetti et al., 2019
myocardium decreased thickness, abnormal standard conditions Fig. 8Fig. S5 from Meneghetti et al., 2019
nucleate erythrocyte aggregated, abnormal standard conditions Fig. S5 from Meneghetti et al., 2019
oocyte atretic, abnormal standard conditions Fig. S6Fig. S11 from Meneghetti et al., 2019
oocyte stage I increased amount, abnormal standard conditions Fig. 8 from Meneghetti et al., 2019
oocyte stage II decreased amount, abnormal standard conditions Fig. 8 from Meneghetti et al., 2019
oocyte stage III decreased amount, abnormal standard conditions Fig. 8 from Meneghetti et al., 2019
oocyte stage IV decreased amount, abnormal standard conditions Fig. 8 from Meneghetti et al., 2019
oocyte stage V decreased amount, abnormal standard conditions Fig. 8 from Meneghetti et al., 2019
ovarian follicle development disrupted, abnormal standard conditions Fig. 8Fig. S6 from Meneghetti et al., 2019
ovary decreased size, abnormal standard conditions Fig. S11 from Meneghetti et al., 2019
seminiferous tubule morphology, abnormal standard conditions Fig. 8 from Meneghetti et al., 2019
skeletal muscle refractivity, abnormal fasting Fig. 4 from Meneghetti et al., 2019
skeletal muscle autophagosome increased amount, abnormal fasting Fig. 4 from Meneghetti et al., 2019
skeletal muscle autophagosome increased amount, abnormal standard conditions Fig. 3 from Meneghetti et al., 2019
skeletal muscle mitochondrial outer membrane dilated, abnormal standard conditions Fig. 3 from Meneghetti et al., 2019
sperm decreased amount, abnormal standard conditions Fig. S7 from Meneghetti et al., 2019
testis fibrotic, abnormal standard conditions Fig. 8Fig. S7 from Meneghetti et al., 2019
testis morphology, abnormal standard conditions Fig. 8Fig. S7 from Meneghetti et al., 2019
trabecular layer morphology, abnormal standard conditions Fig. 8Fig. S5 from Meneghetti et al., 2019
trunk decreased length, abnormal standard conditions Fig. 7 from Meneghetti et al., 2019
whole organism decreased female fertility, abnormal standard conditions Fig. S8 from Meneghetti et al., 2019
whole organism decreased length, abnormal standard conditions Fig. 7 from Meneghetti et al., 2019
whole organism decreased male fertility, abnormal standard conditions Fig. S8 from Meneghetti et al., 2019
whole organism Ab9-map1lc3b labeling increased amount, abnormal fasting Fig. 4 from Meneghetti et al., 2019
whole organism morphology, normal standard conditions Fig. 2 from Meneghetti et al., 2019

CITATIONS  (1)